Cargando…
COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTIs) in infants worldwide. The global direct medical cost associated with RSV LRTIs reaches billions of dollars, with the highest burden in low–middle-income countries. Many efforts have been devoted...
Autores principales: | Gastaldi, Andrea, Donà, Daniele, Barbieri, Elisa, Giaquinto, Carlo, Bont, Louis J., Baraldi, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700687/ https://www.ncbi.nlm.nih.gov/pubmed/34943339 http://dx.doi.org/10.3390/children8121144 |
Ejemplares similares
-
Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
por: De Luca, Daniele, et al.
Publicado: (2023) -
Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015) -
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures
por: Billard, Marie‐Noëlle, et al.
Publicado: (2022) -
Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015) -
Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)